Home   >  
Epigenetics
  >  
Epigenetic Reader Domain

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Epigenetic Reader Domain

Chemical Structure Cat. No. Product Name CAS No.
SNDX-5613 Chemical Structure
BCP36044 SNDX-5613 2169919-21-3
SNDX-5613 is a potent and specific Menin-MLL inhibitor. It can be used for the research of MLL-rearranged (MLL-r) acute leukemias, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).
MI-463 Chemical Structure
BCP36072 MI-463 1628317-18-9
MI-463 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction.
MI-538 Chemical Structure
BCP36073 MI-538 1857417-10-7
MI-538 is an inhibitor of the interaction between menin and MLL fusion proteins with an IC50 of 21 nM.
GSK620 Chemical Structure
BCP35923 GSK620 2088410-46-0
GSK620 is a novel BD2-selective BET inhibitor in vivo tool , binding to the individual tandem bromodomains [BD1 and BD2] of BRD2, BRD3, BRD4, and BRDT.
GSK046 Chemical Structure
BCP35924 GSK046 2474876-09-8
GSK046 (iBET-BD2) is a selective and orally active inhibitor of BET, with IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively.
BRD4 Inhibitor-10 Chemical Structure
BCP35872 BRD4 Inhibitor-10 1660117-38-3
BRD4 Inhibitor-10 is a potent and selective BET inhibitor with IC50 of 5 nM and 41 nM for the binding of BRD4-BD1 and BRD4-BD2 to acetylated histones, respectively. BI 894999 is highly selective for BRD2/3/4 and BRDT (Kd of 0.49-1.6 nM), with at least a 200-fold selectivity vs. BRD4-BD1.
M-89 Chemical Structure
BCP35588 M-89 2363165-42-6
M-89 is a highly potent and specific menin inhibitor, with a Kd of 1.4 nM for binding to menin. M-89 inhibits the menin-mixed lineage leukemia (Menin-MLL) protein-protein interaction and has potential to treat MLL leukemia.
Y06036 Chemical Structure
BCP35043 Y06036 1832671-96-1
Y06036 is a potent and selective BET inhibitor, which binds to the BRD4(1) bromodomain with Kd value of 82 nM. Antitumor activity.
MS31 Chemical Structure
BCP34903 MS31 2366264-12-0
MS31 is a potent, highly affinity and selective fragment-like methyllysine reader protein spindlin 1 (SPIN1) inhibitor. MS31 potently inhibits the interactions between SPIN1 and H3K4me3. It is not toxic to nontumorigenic cells.
VTP-50469 Chemical Structure
BCP34837 VTP-50469 2169916-18-9
VTP50469 is a potent, highly selective and orally active Menin-MLL interaction inhibitor with a Ki of 104 pM. VTP50469 has potently anti-leukemia activity.
123下一页末页共 109 条记录 1 / 11 页 
0086-15971444841